Search

everythinglearnresearchcommunity

for

Search:↓

Capecitabine is as effective as intravenous treatments with fewer side effects, but requires careful management of Hand-foot syndrome and patient education.

Janus kinase inhibitors help hair regrowth in kids with alopecia areata but need more safety research.

DFMO may help control hair growth and treat cancer.

A new one-step test can quickly identify skin cancer during surgery.

Afatinib often causes skin problems that need proactive management.

Lasers can help reduce skin side effects from cancer treatment.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

Imatinib mesylate can cause skin lightening, especially in Chinese patients, due to its effect on pigment production.

The study concludes that the EDA2R gene is activated by p53 during chemotherapy but is not necessary for chemotherapy-induced hair loss.

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.

Deleting vitamin D and calcium receptors in skin cells increases skin cancer risk by reducing DNA repair and stress response.

Vismodegib is effective for basal cell carcinoma but has severe side effects.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Janus kinase inhibitors show promise in treating autoimmune skin diseases.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

Patients with alopecia areata prefer treatments that regrow scalp hair quickly over how often they need to take the medication.

Researchers found a safe and effective way to pick genetically modified skin cells with high growth potential using CD24.

RC48 shows promise for treating certain advanced cancers, but more research is needed.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

CD2 might be a new treatment target for patchy alopecia areata.

New treatments targeting the Hedgehog pathway can help treat advanced skin cancer but may have side effects and their effectiveness in early stages is unknown.

Intralesional cidofovir may be a viable alternative treatment for SCC.

A protein from fat-derived stem cells, DKK1, is linked to hair loss and blocking it may help treat alopecia areata.

Skin cells can naturally limit the growth of cancerous changes by balancing cell renewal and differentiation.

Kidney cancer cells without folliculin are more sensitive to radiation due to increased self-eating cell death.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

Ritlecitinib may help young adults with severe alopecia areata when ketoconazole doesn't work.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.